Cargando…
COVID-19–Related Outcomes in Primary Mitochondrial Diseases: An International Study
BACKGROUND AND OBJECTIVES: To identify factors associated with severe coronavirus disease 2019 (COVID-19), defined by hospitalization status, in patients with primary mitochondrial diseases (PMDs), thereby enabling future risk stratification and informed management decisions. METHODS: We undertook a...
Autores principales: | Pizzamiglio, Chiara, Machado, Pedro M., Thomas, Rhys H., Gorman, Gráinne S., McFarland, Robert, Hanna, Michael G., Pitceathly, Robert D. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992603/ https://www.ncbi.nlm.nih.gov/pubmed/35190464 http://dx.doi.org/10.1212/WNL.0000000000200240 |
Ejemplares similares
-
Mitochondrial disease and COVID-19: An international cohort study confirms risks and long-term outcomes
por: Pizzamiglio, Chiara, et al.
Publicado: (2021) -
Multisystem mitochondrial disease caused by a rare m.10038G>A mitochondrial tRNA(Gly) (MT-TG) variant
por: Poole, Olivia V., et al.
Publicado: (2020) -
Pathogenic mtDNA mutations causing mitochondrial myopathy: The need for muscle biopsy
por: Hardy, Steven A., et al.
Publicado: (2016) -
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus
por: De Vries, Maaike C., et al.
Publicado: (2020) -
Opening One's Eyes to Mosaicism in Progressive External Ophthalmoplegia
por: Sommerville, Ewen W., et al.
Publicado: (2017)